Gearing up for our Annual Scientific Retreat
The Melanoma Research Alliance’s (MRA) annual Scientific Retreat brings together hundreds of scientists, industry professionals, and patients from around the globe to foster collaboration in the field of melanoma research. This year, MRA will host its eighth retreat from February 24-26 in Washington, DC.
Identifying Melanoma as a Single Cell
2 February 2016 In Science
A recent study published in the journal Science could provide important clues for melanoma diagnosis. Led by Leonard Zon, M.D., of Boston Children’s Hospital, the study looked at cancer in zebrafish from the very beginning – when it starts as just a single cell.
A Father Turns His Grief into Fundraising
26 January 2016 In Melanoma Stories
Ross King lost his daughter, Jackie, to melanoma when she was just 22 years old. Since then, Ross has become a passionate supporter of melanoma research to help fulfill a promise he made to Jackie. Ross talked with us about his experience and what motivates him to take up the cause.
Understanding Immunotherapy Part 1: What is Immunotherapy?
If you follow science, you have probably heard about immunotherapy. In just the last year or two, immunotherapy has burst into the mainstream media, with coverage from the New York Times to Time Magazine bringing this emerging field to light beyond the scientific community.
Cancer’s Week in the Spotlight
Cancer has been in the news a lot this week. We learned that two pop-culture artists – David Bowie and Alan Rickman – lost their battles with cancer. It’s a stark contrast to the news we heard last month about President Jimmy Carter, who has had a positive treatment response...
Researcher Q&A: Dr. John D’Orazio
7 January 2016 In Science
In the latest blog post, we chatted with the University of Kentucky’s John D’Orazio, M.D., Ph.D., a pediatric hematologist oncologist, and a 2015 MRA grant awardee. Read on to learn what he has to say about melanoma research and prevention efforts.
Fast and Furious: Melanoma Research in 2015
By Louise M. Perkins, Ph.D., MRA Chief Science Officer | 28 December 2015 In Science, Treatment
The world of melanoma has changed dramatically in a way one might not have envisioned in 2011. How can you tell? From the stories of patients and their caregivers. A common story can go like this: Just diagnosed with Stage 4 melanoma.
Daughter Celebrates Her Mom's Health This Holiday Season
In this guest post, Hilary Rogers, a member of the Leveraged Finance Fights Melanoma Steering Committee, shares her perspective on her mom's battle with melanoma. In the winter of 2012, my family and I found out that our mother’s stage 3 melanoma diagnosis had progressed to her lungs.
Is a Clinical Trial Right for You?
Before the U.S. Food and Drug Administration (FDA) approves a medication or treatment for public use, it first must go through several phases of study which is known as a clinical trial. During each phase, researchers evaluate how well the treatment works and take note of any side effects.
Adjuvant Therapy Advocacy ASCO Awareness Biopharma Board Members BRAF Cancer Combination Therapy Detection FDA Francis Collins Grants Health HHS Immunotherapy Louise Perkins Melanoma microbiome MRA News Nonprofits Partners Patient Forum Patient Stories Patient-Centric Care Patients Pediatric Melanoma Prevention Redheads Research Science Social Media Surgeon General Surgeon General's Call to Action to Prevent Skin Cancer Targeted Therapy Teens Treatment Wendy Selig Young Investigators Young People